Market Cap ₹59 Cr.
Stock P/E -24.8
P/B 0.2
Current Price ₹3.6
Book Value ₹ 16.6
Face Value 10
52W High ₹4.8
Dividend Yield 0%
52W Low ₹ 2.4
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
Profit After Adjustments | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
Adjusted Earnings Per Share | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 1 | 0 | 0 | 0 |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 0 |
Operating Profit | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -1 | -1 | -1 | -1 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 2 | 2 | 2 | 2 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -34 | 0 | -2 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -0 | -38 | -3 | -5 | -3 | -2 | -4 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | -0 | -38 | -3 | -5 | -3 | -2 | -4 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | -38 | -3 | -5 | -3 | -2 | -4 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 0 | -0 | -2.4 | -0.2 | -0.3 | -0.2 | -0.2 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 41% | 53% | 37% | 11% |
ROE Average | -1% | -1% | -3% | -2% |
ROCE Average | -1% | -1% | -2% | -1% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 328 | 328 | 328 | 328 | 333 | 323 | 285 | 282 | 277 | 274 | 272 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 604 | 606 | 607 | 608 | 299 | 191 | 173 | 172 | 173 | 173 | 174 |
Other Non-Current Liabilities | 11 | 11 | 7 | 7 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 4 | 1 | 1 | 0 | 1 | 1 |
Total Liabilities | 942 | 944 | 943 | 944 | 633 | 518 | 459 | 455 | 451 | 449 | 447 |
Fixed Assets | 7 | 7 | 4 | 4 | 382 | 497 | 353 | 350 | 346 | 344 | 342 |
Other Non-Current Assets | 935 | 937 | 939 | 940 | 248 | 22 | 106 | 105 | 105 | 105 | 105 |
Total Current Assets | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Assets | 942 | 944 | 943 | 944 | 633 | 518 | 459 | 455 | 451 | 449 | 447 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash Flow from Operating Activities | -0 | 0 | -0 | 0 | -0 | 4 | -5 | -1 | -0 | -1 | -1 |
Cash Flow from Investing Activities | -2 | -0 | -2 | -2 | -2 | -1 | 22 | 1 | 0 | -0 | -0 |
Cash Flow from Financing Activities | 2 | 0 | 2 | 2 | 2 | -4 | -18 | -1 | 0 | 1 | 1 |
Net Cash Inflow / Outflow | 0 | 0 | -0 | -0 | -0 | -0 | 0 | -0 | 0 | 0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0 | 0 | 0 | 0 | 0 | -0.02 | -2.36 | -0.18 | -0.3 | -0.16 | -0.15 |
CEPS(Rs) | 0 | 0 | 0 | 0 | 0 | -0.01 | -2.12 | -0.06 | -0.18 | -0.05 | -0.03 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 20.24 | 20.24 | 20.28 | 20.23 | 20.59 | 19.95 | 17.59 | 17.41 | 17.11 | 16.95 | 16.79 |
Core EBITDA Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | -4807.33 | -947.04 | -155.33 | -171.46 | -318.75 |
EBIT Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2155.26 | -1058.28 | -609.66 | -1371.65 |
Pre Tax Margin(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2155.26 | -1058.28 | -609.66 | -1371.65 |
PAT Margin (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2155.26 | -1058.28 | -609.66 | -1371.65 |
Cash Profit Margin (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -708.52 | -638.62 | -169.82 | -311.75 |
ROA(%) | 0 | 0 | 0 | 0 | 0 | -0.05 | -7.81 | -0.64 | -1.07 | -0.59 | -0.55 |
ROE(%) | 0 | 0 | 0 | 0 | 0 | -0.09 | -12.56 | -1.03 | -1.73 | -0.97 | -0.91 |
ROCE(%) | 0 | 0 | 0 | 0 | 0 | -0.05 | -7.86 | -0.64 | -1.07 | -0.59 | -0.56 |
Receivable days | 0 | 0 | 0 | 0 | 0 | 0 | 365 | 451.25 | 209.33 | 181.96 | 393.59 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 26.36 | 6.89 | 3.59 | 3.63 | 1.41 |
Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.08 | 0.06 | 0.29 | 0.13 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0 | 0 | 0 | 0 | 0 | 0 | 4118.26 | 1434.85 | 412.19 | 575.56 | 1155.03 |
EV/Core EBITDA(x) | 0 | 0 | 0 | 0 | 0 | -886.21 | -652.77 | -202.51 | -355.64 | -338.93 | -370.5 |
Net Sales Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 200 | 239.11 | -4.54 | -58.51 |
EBIT Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92.37 | -66.51 | 45.01 | 6.66 |
PAT Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92.37 | -66.51 | 45.01 | 6.66 |
EPS Growth(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 92.37 | -66.5 | 45.01 | 6.68 |
Debt/Equity(x) | 1.84 | 1.85 | 1.85 | 1.86 | 0.9 | 0.59 | 0.61 | 0.61 | 0.62 | 0.63 | 0.64 |
Current Ratio(x) | 1.28 | 1.64 | 1.31 | 1.04 | 6.99 | 0.02 | 0.15 | 0.39 | 0.83 | 0.41 | 0.52 |
Quick Ratio(x) | 1.28 | 1.52 | 1.24 | 1.03 | 1.07 | 0.01 | 0.15 | 0.39 | 0.81 | 0.41 | 0.52 |
Interest Cover(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Debt/Mcap(x) | 0 | 54.61 | 65.28 | 62.18 | 22.92 | 15.39 | 13.96 | 8.01 | 10.58 | 2.19 | 4.93 |
# | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 47.71 | 47.71 | 47.71 | 47.71 | 47.71 | 47.71 | 47.79 | 47.71 | 47.95 | 47.87 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Public | 52.26 | 52.26 | 52.26 | 52.26 | 52.26 | 52.26 | 52.18 | 52.26 | 52.02 | 52.1 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.5 | 8.52 | 8.44 | 8.47 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.31 | 16.28 | 16.31 | 16.23 | 16.25 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About